{"organizations": [], "uuid": "637f5cb515ff9dfc55b266a3b1e33a304150142a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180213.html", "section_title": "Archive News &amp; Video for Tuesday, 13 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/csl-ltd-results/australias-csls-half-year-profit-jumps-35-percent-on-profit-rise-idUSL4N1Q403Y", "country": "US", "domain_rank": 408, "title": "Australia's CSL's half-year profit jumps 35 percent on profit rise", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-14T08:20:00.000+02:00", "replies_count": 0, "uuid": "637f5cb515ff9dfc55b266a3b1e33a304150142a"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/csl-ltd-results/australias-csls-half-year-profit-jumps-35-percent-on-profit-rise-idUSL4N1Q403Y", "ord_in_thread": 0, "title": "Australia's CSL's half-year profit jumps 35 percent on profit rise", "locations": [], "entities": {"persons": [{"name": "sumeet gaikwad", "sentiment": "none"}, {"name": "paul tait", "sentiment": "none"}], "locations": [{"name": "australia", "sentiment": "none"}, {"name": "bengaluru", "sentiment": "none"}], "organizations": [{"name": "csl ltd", "sentiment": "negative"}, {"name": "csl", "sentiment": "negative"}, {"name": "reuters) - biotherapeutics", "sentiment": "neutral"}, {"name": "thomson reuters trust principles", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 14 (Reuters) - Biotherapeutics company CSL Ltd reported a 35 percent rise in its first half profit on Wednesday and upgraded its earnings guidance for the fiscal year.\nNet profit after tax was $1.1 billion, the company said, compared with $805.5 million a year ago.\nCSL also upgraded its fiscal 2018 earnings guidance to about $1.55 billion-$1.60 billion from an earlier forecast of $1.48 billion-$1.55 billion.\nThe companyâ€™s stock rose as much as 6 percent after it announced its results and is among the top gainers on the benchmark Australian index. (Reporting by Sumeet Gaikwad in Bengaluru; Editing by Paul Tait)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-14T08:20:00.000+02:00", "crawled": "2018-02-14T12:36:03.083+02:00", "highlightTitle": ""}